<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Medicine &#187; Drugs</title>
	<atom:link href="http://www.canadianmedicine4all.com/category/drugs/feed" rel="self" type="application/rss+xml" />
	<link>http://www.canadianmedicine4all.com</link>
	<description></description>
	<lastBuildDate>Thu, 26 Jan 2012 08:54:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Provocation Test Coupled with Bronchoaiveoiar Lavage in Diagnosis off Drug (Nilutamide): DISCUSSION</title>
		<link>http://www.canadianmedicine4all.com/provocation-test-coupled-with-bronchoaiveoiar-lavage-in-diagnosis-off-drug-nilutamide-discussion.html</link>
		<comments>http://www.canadianmedicine4all.com/provocation-test-coupled-with-bronchoaiveoiar-lavage-in-diagnosis-off-drug-nilutamide-discussion.html#comments</comments>
		<pubDate>Wed, 20 Apr 2011 22:17:11 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Bronchoaiveoiar Lavage]]></category>

		<guid isPermaLink="false">http://www.canadianmedicine4all.com/?p=2529</guid>
		<description><![CDATA[Nilutamide is a nonsteroidal anti-androgen newly available for the treatment of prostatic cancer.1 In a case recently reported, it has been considered responsible for an inter­stitial pneumonitis occurring after a treatment of two months (cumulative dose: 12.5 g) and disappearing three months after the drug was withdrawn; in BAL fluid, there was a lymphocytosis (55 [...]]]></description>
		<wfw:commentRss>http://www.canadianmedicine4all.com/provocation-test-coupled-with-bronchoaiveoiar-lavage-in-diagnosis-off-drug-nilutamide-discussion.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Provocation Test Coupled with Bronchoaiveoiar Lavage in Diagnosis off Drug (Nilutamide)</title>
		<link>http://www.canadianmedicine4all.com/provocation-test-coupled-with-bronchoaiveoiar-lavage-in-diagnosis-off-drug-nilutamide.html</link>
		<comments>http://www.canadianmedicine4all.com/provocation-test-coupled-with-bronchoaiveoiar-lavage-in-diagnosis-off-drug-nilutamide.html#comments</comments>
		<pubDate>Tue, 19 Apr 2011 06:14:13 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Bronchoaiveoiar Lavage]]></category>

		<guid isPermaLink="false">http://www.canadianmedicine4all.com/?p=2527</guid>
		<description><![CDATA[The case we are reporting here is that of a patient whose interstitial pneumonitis seemed to be induced by nilu­tamide, a newly available active drug for prostate cancer treatment. The correlation between variations of BAL cell data sequentially evaluated and the provocation test with this drug would appear to exemplify the possible diagnostic interest in [...]]]></description>
		<wfw:commentRss>http://www.canadianmedicine4all.com/provocation-test-coupled-with-bronchoaiveoiar-lavage-in-diagnosis-off-drug-nilutamide.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pulsed Nasal and Transtracheal Oxygen Delivery: DISCUSSION continue</title>
		<link>http://www.canadianmedicine4all.com/pulsed-nasal-and-transtracheal-oxygen-delivery-discussion-continue.html</link>
		<comments>http://www.canadianmedicine4all.com/pulsed-nasal-and-transtracheal-oxygen-delivery-discussion-continue.html#comments</comments>
		<pubDate>Wed, 06 Apr 2011 15:06:50 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Pulsed Nasal]]></category>
		<category><![CDATA[Transtracheal Oxygen Delivery]]></category>

		<guid isPermaLink="false">http://www.canadianmedicine4all.com/?p=2471</guid>
		<description><![CDATA[This study shows that, compared with continuous flow TTO, pulsed transtracheal oxygen improves the efficiency of oxygen delivery by a factor of 3:1 while achieving an equivalent Sa02. Previous studies have shown that continuous flow TTO therapy improves the efficiency of oxygen delivery by between 2:1 and 3:1 over continuous flow nasal oxygen therapy. If [...]]]></description>
		<wfw:commentRss>http://www.canadianmedicine4all.com/pulsed-nasal-and-transtracheal-oxygen-delivery-discussion-continue.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pulsed Nasal and Transtracheal Oxygen Delivery: DISCUSSION</title>
		<link>http://www.canadianmedicine4all.com/pulsed-nasal-and-transtracheal-oxygen-delivery-discussion.html</link>
		<comments>http://www.canadianmedicine4all.com/pulsed-nasal-and-transtracheal-oxygen-delivery-discussion.html#comments</comments>
		<pubDate>Wed, 06 Apr 2011 01:05:55 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Pulsed Nasal]]></category>
		<category><![CDATA[Transtracheal Oxygen Delivery]]></category>

		<guid isPermaLink="false">http://www.canadianmedicine4all.com/?p=2470</guid>
		<description><![CDATA[This study demonstrates that the efficiency of nasal oxygen therapy is improved by early delivery of the inspiratory pulse; the Sa02 increases progressively as the delay between the inspiratory signal and the delivery of the pulse is shortened. In contrast, delays in delivery of transtracheal pulses up to 164 ms has no effect on Sa02. [...]]]></description>
		<wfw:commentRss>http://www.canadianmedicine4all.com/pulsed-nasal-and-transtracheal-oxygen-delivery-discussion.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

